Zobrazeno 1 - 10
of 593
pro vyhledávání: '"Fessart, D"'
Autor:
Fessart D; ARTiSt Lab, Université de Bordeaux, Inserm U1312, 33000 Bordeaux, France., Delom F; ARTiSt Lab, Université de Bordeaux, Inserm U1312, 33000 Bordeaux, France. Electronic address: frederic.delom@u-bordeaux.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Feb; Vol. 111 (2), pp. 235-236. Date of Electronic Publication: 2023 Oct 21.
Autor:
Pernot S; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France., Tomé M; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France., Galeano-Otero I; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France., Evrard S; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France., Badiola I; Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Delom F; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France., Fessart D; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France., Smani T; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocío/University of Seville/CSIC, Seville, Spain., Siegfried G; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France., Villoutreix BO; Integrative Computational Pharmacology and Data Mining, INSERM UMR 1141, Rob-ert-Debré Hospital, Paris, France., Khatib AM; Reprograming tumor activitY and associaTed MicroenvironmEnt (Rytme), Bordeaux Institute of Oncology (BRIC)-UMR1312 Inserm, Université of Bordeaux, Pessac, France.; Institut Bergonié, Bordeaux, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jan 05; Vol. 14, pp. 1278630. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2023).
Autor:
Fessart D; ARTiSt lab, Université de Bordeaux, Inserm U1312 BRIC, 33000 Bordeaux, France. Electronic address: delphine.fessart@inserm.fr., Robert J; ARTiSt lab, Université de Bordeaux, Inserm U1312 BRIC, 33000 Bordeaux, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Jan; Vol. 111 (1), pp. 37-50. Date of Electronic Publication: 2023 Sep 09.
Autor:
Maurel, M, Obacz, J, Avril, T, Ding, Y-P, Papadodima, O, Treton, X, Daniel, F, Pilalis, E, Hörberg, J, Hou, W, Beauchamp, M-C, Tourneur-Marsille, J, Cazals-Hatem, D, Sommerova, L, Samali, A, Tavernier, J, Hrstka, R, Dupont, A, Fessart, D, Delom, F, Fernandez-Zapico, ME, Jansen, G, Eriksson, LA, Thomas, DY, Jerome-Majewska, L, Hupp, T, Chatziioannou, A, Chevet, E, Ogier-Denis, E
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2019, 11 (6), pp.e10120. ⟨10.15252/emmm.201810120⟩
EMBO Molecular Medicine, 2019, 11 (6), pp.e10120. ⟨10.15252/emmm.201810120⟩
Maurel, M, Obacz, J, Avril, T, Ding, YP, Papadodima, O, Treton, X, Daniel, F, Pilalis, E, Hörberg, J, Hou, W, Beauchamp, MC, Tourneur-Marsille, J, Cazals-Hatem, D, Sommerova, L, Samali, A, Tavernier, J, Hrstka, R, Dupont, A, Fessart, D, Delom, F, Fernandez-Zapico, M E, Jansen, G, Eriksson, L A, Thomas, D Y, Jerome-Majewska, L, Hupp, T, Chatziioannou, A, Chevet, E & Ogier-Denis, E 2019, ' Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation ', EMBO Molecular Medicine, vol. 11, no. 6, e10120 . https://doi.org/10.15252/emmm.201810120
EMBO Molecular Medicine, Vol 11, Iss 6, Pp n/a-n/a (2019)
EMBO Molecular Medicine, Wiley Open Access, 2019, 11 (6), pp.e10120. ⟨10.15252/emmm.201810120⟩
EMBO Molecular Medicine, 2019, 11 (6), pp.e10120. ⟨10.15252/emmm.201810120⟩
Maurel, M, Obacz, J, Avril, T, Ding, YP, Papadodima, O, Treton, X, Daniel, F, Pilalis, E, Hörberg, J, Hou, W, Beauchamp, MC, Tourneur-Marsille, J, Cazals-Hatem, D, Sommerova, L, Samali, A, Tavernier, J, Hrstka, R, Dupont, A, Fessart, D, Delom, F, Fernandez-Zapico, M E, Jansen, G, Eriksson, L A, Thomas, D Y, Jerome-Majewska, L, Hupp, T, Chatziioannou, A, Chevet, E & Ogier-Denis, E 2019, ' Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation ', EMBO Molecular Medicine, vol. 11, no. 6, e10120 . https://doi.org/10.15252/emmm.201810120
EMBO Molecular Medicine, Vol 11, Iss 6, Pp n/a-n/a (2019)
International audience; Anterior gradient 2 (AGR2) is a dimeric protein disulfide isomerase family member involved in the regulation of protein quality control in the endoplasmic reticulum (ER). Mouse AGR2 deletion increases intestinal inflammation a
Autor:
Chevet E; U1242, INSERM, Rennes, France Eric.chevet@inserm.fr.; Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France.; University of Rennes, Rennes, France., Bassal F; Thabor Therapeutics, Paris, France., Beq S; Thabor Therapeutics, Paris, France., Bonhomme B; Institut Bergonié, Bordeaux, France., Boisteau E; U1242, INSERM, Rennes, France.; Department of Gastroenterology, CHU Rennes, Rennes, France., Calloch J; Thabor Therapeutics, Paris, France., Cazals-Hatem D; Gastroenterology, IBD and intestinal failure department, Beaujon Hospital, Clichy, France., Delom F; Bordeaux II University, Talence, France.; U1312, INSERM, Bordeaux, France., Fessart D; Bordeaux II University, Talence, France.; U1312, INSERM, Bordeaux, France., Evrard S; Institut Bergonié, Bordeaux, France.; Bordeaux II University, Talence, France., Hrstka R; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Hupp T; University of Edinbhurg, Edinburgh, UK., Lièvre A; Department of Gastroenterology, CHU Rennes, Rennes, France., Louis E; Hepato-gastroenterology and digestive oncology, University Hospital CHU of Liège and laboratory of translational gastroenterology, GIGA institute, ULiège, Liège, Belgium., Mariau J; Thabor Therapeutics, Paris, France., Meuwis MA; Hepato-gastroenterology and digestive oncology, University Hospital CHU of Liège and laboratory of translational gastroenterology, GIGA institute, ULiège, Liège, Belgium., Ogier-Denis E; U1242, INSERM, Rennes, France.; Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France.; University of Rennes, Rennes, France., Paradis V; Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Clichy, France., Pernot S; Institut Bergonié, Bordeaux, France., Pineau R; U1242, INSERM, Rennes, France.; Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France.; University of Rennes, Rennes, France., Treton X; Gastroenterology Department, Hôpital Beaujon, MICI et Assistance Nutritive, APHP, Paris, France., Velasco V; Institut Bergonié, Bordeaux, France., Vieujean S; Hepato-gastroenterology and digestive oncology, University Hospital CHU of Liège and laboratory of translational gastroenterology, GIGA institute, ULiège, Liège, Belgium.
Publikováno v:
Gut [Gut] 2022 Dec 09. Date of Electronic Publication: 2022 Dec 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fessart D; ARTiSt, University Bordeaux, INSERM U1312, Bordeaux F-33000, France.; POETIC, University Bordeaux, INSERM U1312, Bordeaux F-33000, France., Villamor I; POETIC, University Bordeaux, INSERM U1312, Bordeaux F-33000, France., Chevet E; INSERM U1242, 'Chemistry, Oncogenesis Stress Signaling', Université Rennes 1, Rennes, France.; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Delom F; ARTiSt, University Bordeaux, INSERM U1312, Bordeaux F-33000, France., Robert J; ARTiSt, University Bordeaux, INSERM U1312, Bordeaux F-33000, France.
Publikováno v:
Open biology [Open Biol] 2022 Jul; Vol. 12 (7), pp. 220068. Date of Electronic Publication: 2022 Jul 13.
Autor:
Delom F; ARTiSt group, Univ Bordeaux, Inserm, Institut Bergonié, ACTION, U1218, 33000 Bordeaux, France., Le Morvan V; ARTiSt group, Univ Bordeaux, Inserm, Institut Bergonié, ACTION, U1218, 33000 Bordeaux, France., Robert J; ARTiSt group, Univ Bordeaux, Inserm, Institut Bergonié, ACTION, U1218, 33000 Bordeaux, France., Fessart D; ARTiSt group, Univ Bordeaux, Inserm, Institut Bergonié, ACTION, U1218, 33000 Bordeaux, France; Inserm U1242, 'chemistry, oncogenesis stress signaling', université Rennes 1, 35000 Rennes, France; Centre de lutte contre le cancer Eugène Marquis, 35000 Rennes, France. Electronic address: delphine.fessart@inserm.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2022 Jan; Vol. 109 (1), pp. 58-64. Date of Electronic Publication: 2021 Dec 10.
Autor:
Fessart D; INSERM U1242, 'Chemistry, Oncogenesis Stress Signaling', Université Rennes 1, Rennes, France. delphine.fessart@inserm.fr.; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. delphine.fessart@inserm.fr.; ARTiSt group, Univ. Bordeaux, INSERM, Institut Bergonié, ACTION, U1218, F-33000, Bordeaux, France. delphine.fessart@inserm.fr., Robert J; ARTiSt group, Univ. Bordeaux, INSERM, Institut Bergonié, ACTION, U1218, F-33000, Bordeaux, France., Hartog C; ARTiSt group, Univ. Bordeaux, INSERM, Institut Bergonié, ACTION, U1218, F-33000, Bordeaux, France., Chevet E; INSERM U1242, 'Chemistry, Oncogenesis Stress Signaling', Université Rennes 1, Rennes, France.; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Delom F; ARTiSt group, Univ. Bordeaux, INSERM, Institut Bergonié, ACTION, U1218, F-33000, Bordeaux, France. frederic.delom@u-bordeaux.fr., Babin G; ARTiSt group, Univ. Bordeaux, INSERM, Institut Bergonié, ACTION, U1218, F-33000, Bordeaux, France. g.babin@bordeaux.unicancer.fr.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Aug 27; Vol. 40 (1), pp. 271. Date of Electronic Publication: 2021 Aug 27.
Autor:
Chevet, E1, Fessart, D2, Delom, F2, Mulot, A1, Vojtesek, B3, Hrstka, R3, Murray, E4, Gray, T5, Hupp, T5
Publikováno v:
Oncogene. 5/16/2013, Vol. 32 Issue 20, p2499-2509. 11p. 5 Diagrams, 1 Chart.